Literature DB >> 11377014

Omeprazole determination using HPLC with coulometric detection.

G W Sluggett1, J D Stong, J H Adams, Z Zhao.   

Abstract

A sensitive high performance liquid chromatography (HPLC) method for the determination of omeprazole and three related benzimidazoles is reported. Coulometric detection was carried out at +800 mV using a porous carbon electrode. The linear range is 0.01-10 microg/ml. The method has a high degree of precision; the relative standard deviation of omeprazole at a concentration of 1.06 microg/ml was 0.7% (n=4). The cyclic voltammogram of omeprazole is consistent with the hydrodynamic voltammogram exhibiting a single major irreversible oxidative wave with a peak potential at +1105 mV. The response factors for the four compounds are similar indicating that the oxidative process does not involve the sulfur moiety exclusively. The data are most consistent with oxidation primarily of the benzimidazole groups. The method was applied successfully to the determination of omeprazole in a paste formulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377014     DOI: 10.1016/s0731-7085(00)00519-7

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Simultaneous Estimation of Esomeprazole and Domperidone by UV Spectrophotometric Method.

Authors:  S Lakshmana Prabu; A Shirwaikar; Annie Shirwaikar; C Dinesh Kumar; A Joseph; R Kumar
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

2.  Voltammetric Behavior and Determination of Trace Amounts of Omeprazole Using an Edge-plane Pyrolytic Graphite Electrode.

Authors:  Saeed Shahrokhian; Masoumeh Ghalkhani; Maryam Bayat; Fatemeh Ghorbani-Bidkorbeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

3.  A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form.

Authors:  P B Raval; Manisha Puranik; S J Wadher; P G Yeole
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.